Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food safety testing reagents and instruments in China and international...
CEC Capital advises Zhongkexinyang on 100-million-yuan private financing round
Pre-market hot trades in US stocks: Planet Green fell 3.89% in pre-market; IREN rose 3.82% in pre-market
Bioeasy released its performance for the first three quarters, with a net profit attributable to the parent company of 18.023 million yuan, an increase of 362.49%
Bioeasy's controlling shareholder and its concerted parties plan to reduce their holdings by no more than 3%
Bioeasy: Net profit of 2.3395 million yuan in the first half of 2025, turning a profit from a loss year-on-year
Bioeasy: Yi Rui Venture Capital and Zhu Hai plan to reduce their holdings of the company's shares by 0.88% and 1.87%, respectively